$7.960
-0.390 (-4.90%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Atara Biotherapeutics, Inc. (ATRA) Moving Averages Convergence Divergence (MACD) indicator is -0.27, suggesting ATRA is Strong sell.
Atara Biotherapeutics, Inc. (ATRA) 20-Day simple moving average is 8.85, while Atara Biotherapeutics, Inc. (ATRA) share price is $—, making it Sell.
Atara Biotherapeutics, Inc. (ATRA) 60-Day simple moving average is 9.09, while Atara Biotherapeutics, Inc. (ATRA) share price is $—, making it Sell.
Technical Analysis for ATRA
AI Technical ATRAAs of 2026-11-03, the technical board for Atara Biotherapeutics, Inc. (ATRA) reads strong sell: 2 indicators are flashing buy, 8 are indicating sell, and 3 are neutral. Price at $7.96 sits below the 5-day, 10-day, 20-day and 60-day moving averages and above the 200-day.
Momentum readings: RSI stands at 40.039, MACD stands at -0.269 (Sell), Stochastic %K stands at 24.661, Stochastic %D stands at 26.277 and CCI stands at -128.083 (Buy).
ATRA trades below the 60-day SMA (9.09) and above the 200-day SMA (7.75). Immediate resistance sits at Classic R1 9.33, then R2 10.30. Support sits at Classic S1 7.43, then S2 6.50.
Atara Biotherapeutics, Inc. (ATRA) Support & Resistance Level
Atara Biotherapeutics, Inc. (ATRA) Technical Indicators
2026-11-03
| Name | Value |
|---|---|
| RSI_14 | 40.039 |
| STOCHk_14_3_3 | 24.661 |
| STOCHd_14_3_3 | 26.277 |
| CCI_20 | -128.083 |
| AO_5_34 | -0.663 |
| MOM_10 | -1.470 |
| MACD_12_26_9 | -0.269 |
Atara Biotherapeutics, Inc. (ATRA) Relative Strength Index (RSI_14) is 40.039, creating a Neutral signal.
Atara Biotherapeutics, Inc. (ATRA) Stochastic %K is 24.661, creating a Neutral signal.
Atara Biotherapeutics, Inc. (ATRA) Stochastic %D is 26.277, creating a Neutral signal.
Atara Biotherapeutics, Inc. (ATRA) CCI_20 is -128.083, creating a Buy signal.
Atara Biotherapeutics, Inc. (ATRA) Awesome Oscillator (AO) is -0.663, creating a Sell signal.
Atara Biotherapeutics, Inc. (ATRA) Momentum (MOM) is -1.470, creating a Sell signal.
Atara Biotherapeutics, Inc. (ATRA) Moving Average Convergence Divergence (MACD) is -0.269, creating a Sell signal.
Atara Biotherapeutics, Inc. (ATRA) Moving Average
2026-11-03
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 8.226 | Sell |
| MA_10 | 8.356 | Sell |
| MA_20 | 8.851 | Sell |
| MA_60 | 9.093 | Sell |
| MA_200 | 7.754 | Buy |
| MA_250 | 8.970 | Sell |
Atara Biotherapeutics, Inc. (ATRA) 5-Day simple moving average is 8.226, while Atara Biotherapeutics, Inc. (ATRA) share price is $, making it a Sell.
Atara Biotherapeutics, Inc. (ATRA) 10-Day simple moving average is 8.356, while Atara Biotherapeutics, Inc. (ATRA) share price is $, making it a Sell.
Atara Biotherapeutics, Inc. (ATRA) 20-Day simple moving average is 8.851, while Atara Biotherapeutics, Inc. (ATRA) share price is $, making it a Sell.
Atara Biotherapeutics, Inc. (ATRA) 60-Day simple moving average is 9.093, while Atara Biotherapeutics, Inc. (ATRA) share price is $, making it a Sell.
Atara Biotherapeutics, Inc. (ATRA) 200-Day simple moving average is 7.754, while Atara Biotherapeutics, Inc. (ATRA) share price is $, making it a Buy.
Atara Biotherapeutics, Inc. (ATRA) 250-Day simple moving average is 8.970, while Atara Biotherapeutics, Inc. (ATRA) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.